… Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(… A weighted pooled analysis of available studies was performed to evaluate clinical outcome …

… major importance in the clinical outcome of patients with NSCLC (Table 2), and the immune
contexture should be taken into account in the clinical management of patients with cancer. …

… In conclusion, the five-gene expression signature we identified is closely associated with
the clinical outcome in patients with surgically resected NSCLC. This signature could be useful …

… ) results—was representative of known features of patients with non–small cell lung cancer
(NSCLC), could replicate well-established genomic correlations with clinical outcomes, and …

… responses to lung tumors may be present, and their magnitude may correlate with patient
outcome. Retrospective analyses of tumor specimens from lung cancer patients suggest that …

… clinical outcomes of LM in NSCLC patients in the modern chemotherapy era by analyzing
clinical … We have summarized the treatment and clinical outcomes of IT chemotherapy in Table …

… treatments and prognostic implications for clinicians. Here, we describe clinical outcomes
from a large retrospective cohort of patients with EGFR-mutant SCLC transformed cancers. …

… the clinical outcome of treatment using real-time tumor tracking … with inoperable stage I
non-small cell lung cancer (NSCLC). … clinical results have been published for the treatment of lung …

… To explore the potential impact of EGFR and KRAS genotypes on clinical outcomes of
chemotherapy-naïve Western patients with non–small cell lung cancer treated with an EGFR-TKI, …

… Given our clinical results, additional dose escalation studies may be possible. However,
patients receiving BED ≥ 120 Gy or ≥ 140 Gy did not display significantly better local control …